Organogenesis Holdings Inc
NASDAQ:ORGO
Organogenesis Holdings Inc
NASDAQ:ORGO
Price:
2.29
USD
-5.37%
Market Closed
Market Cap:
$294.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Organogenesis Holdings Inc
NASDAQ:ORGO
|
US |
|
IIFL Capital Services Ltd
NSE:IIFLCAPS
|
IN |
|
AMG Advanced Metallurgical Group NV
LSE:0LO9
|
NL |
|
S
|
Suzhou Oriental Semiconductor Co Ltd
SSE:688261
|
CN |
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
CN |
Balance Sheet
Balance Sheet Decomposition
Organogenesis Holdings Inc
Organogenesis Holdings Inc
Balance Sheet Decomposition is not available for
Organogenesis Holdings Inc
Organogenesis Holdings Inc
Balance Sheet
Organogenesis Holdings Inc
Organogenesis Holdings Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
21
|
60
|
84
|
114
|
103
|
104
|
136
|
94
|
|
| Cash |
0
|
1
|
0
|
21
|
60
|
84
|
114
|
103
|
104
|
136
|
94
|
|
| Total Receivables |
0
|
0
|
0
|
34
|
39
|
57
|
83
|
90
|
82
|
110
|
217
|
|
| Accounts Receivables |
0
|
0
|
0
|
34
|
39
|
57
|
83
|
90
|
82
|
110
|
217
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
13
|
23
|
28
|
25
|
25
|
28
|
26
|
30
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
3
|
5
|
6
|
6
|
11
|
14
|
21
|
|
| Total Current Assets |
0
|
1
|
0
|
71
|
126
|
174
|
227
|
223
|
225
|
286
|
362
|
|
| PP&E Net |
0
|
0
|
0
|
40
|
47
|
60
|
128
|
146
|
156
|
126
|
159
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
47
|
60
|
128
|
146
|
156
|
126
|
159
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
66
|
70
|
58
|
63
|
73
|
73
|
88
|
|
| Intangible Assets |
0
|
0
|
0
|
26
|
21
|
31
|
26
|
21
|
16
|
12
|
9
|
|
| Goodwill |
0
|
0
|
0
|
26
|
26
|
29
|
29
|
29
|
29
|
29
|
29
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
310
|
313
|
1
|
1
|
1
|
34
|
32
|
34
|
44
|
39
|
|
| Other Assets |
0
|
0
|
0
|
26
|
26
|
29
|
29
|
29
|
29
|
29
|
29
|
|
| Total Assets |
0
N/A
|
311
+77 750%
|
313
+0%
|
164
-48%
|
221
+35%
|
295
+33%
|
443
+51%
|
449
+1%
|
460
+2%
|
498
+8%
|
599
+20%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
19
|
28
|
23
|
29
|
32
|
31
|
29
|
32
|
|
| Accrued Liabilities |
0
|
0
|
4
|
0
|
24
|
24
|
48
|
38
|
43
|
39
|
56
|
|
| Short-Term Debt |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
8
|
3
|
20
|
3
|
5
|
7
|
1
|
9
|
|
| Other Current Liabilities |
0
|
0
|
0
|
37
|
5
|
1
|
1
|
0
|
0
|
9
|
3
|
|
| Total Current Liabilities |
0
|
1
|
4
|
66
|
60
|
68
|
82
|
75
|
81
|
77
|
100
|
|
| Long-Term Debt |
0
|
0
|
0
|
49
|
98
|
65
|
71
|
66
|
63
|
1
|
13
|
|
| Other Liabilities |
0
|
11
|
11
|
1
|
8
|
16
|
49
|
42
|
38
|
34
|
52
|
|
| Total Liabilities |
0
N/A
|
11
+2 725%
|
15
+31%
|
117
+688%
|
165
+42%
|
148
-10%
|
201
+36%
|
184
-9%
|
181
-1%
|
113
-38%
|
165
+46%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
295
|
293
|
0
|
0
|
0
|
0
|
0
|
0
|
122
|
134
|
|
| Retained Earnings |
0
|
0
|
2
|
130
|
171
|
153
|
60
|
45
|
41
|
40
|
3
|
|
| Additional Paid In Capital |
0
|
5
|
7
|
177
|
227
|
299
|
302
|
311
|
320
|
303
|
303
|
|
| Total Equity |
0
N/A
|
300
N/A
|
298
-1%
|
47
-84%
|
56
+18%
|
146
+163%
|
242
+66%
|
266
+10%
|
279
+5%
|
385
+38%
|
434
+13%
|
|
| Total Liabilities & Equity |
0
N/A
|
311
+77 750%
|
313
+0%
|
164
-48%
|
221
+35%
|
295
+33%
|
443
+51%
|
449
+1%
|
460
+2%
|
498
+8%
|
599
+20%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
38
|
39
|
39
|
91
|
105
|
128
|
129
|
131
|
131
|
126
|
127
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
